跳至主要内容
临床试验/CTRI/2024/08/073156
CTRI/2024/08/073156尚未招募2/3 期

Randomized Controlled Clinical Trial to Evaluate the Efficacy of Ghoshaphalvarti as arshoghna in the management of Arsha (2 Degree Internal Haemorrhoids)

CSMSS Ayurved College Kanchanwadi Chhatrapati Sambhajinagar1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2024年9月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
92
试验地点
1
主要终点
Bleeding, constipation, Size of Arshankur reduces on 1st,3rd,5th and 7th day

研究概览

简要总结

The worldwide Prevalence rate of Hemorrhoids is 4.4%.

It is a Common Ano-Rectal disease that is gradually increasing due to an Unhealthy Diet & sedentary Lifestyle etc.

Rectal Supossitory is one of the important modalities to be used in the initial phases.

Varti Kalpana is one of the important modalities to be used in the initial phases. In the Initial phases i.e. (I & II-degree Haemorrhoids) are treated with the help of conservative management and other surgical modalities are to be avoided. Varti Prayog comes under Shashti Upakrama having local action in Arshas. For those patients who do not respond to oral medicinal treatment the local treatments deserve its importance in them. Local treatment also gives immediate relief when it is combined with conservative treatment. Local resources are simple in technique with minimum complication and Easily managable.

The study will be conducted on 92 diagnosed patients with 2-degree internal hemorrhoid

written consent, initial assessment

the patient will be divided into 2 groups

Trial Group-A-Ghoshaphalvarti

Control Group-B- Kasisaditailvarti

observations and results will be noted

Discussion and Conclusion

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient having 2nd degree Haemorrhoids patient having Age 20-60 years selection of Patients will be done irrespective of sex, religion & socioeconomic class.

排除标准

  • Patient having 3rd and 4th Degree Haemorrhoids patient having CA Rectum & Anal Canal Pregnancy.
  • patient having DM, HTN, HIV, HBsAg, Tuberculosis & any other Systemic Disorder.

结局指标

主要结局

Bleeding, constipation, Size of Arshankur reduces on 1st,3rd,5th and 7th day

时间窗: 7 Days

次要结局

未报告次要终点

研究者

发起方
CSMSS Ayurved College Kanchanwadi Chhatrapati Sambhajinagar
申办方类型
Other [self ]
责任方
Principal Investigator
主要研究者

DrBhakti Rambhau Shewale

CSMSS Ayurved College kanchanwadi, Chhatrapati Sambhajingar Department of Shalyatantra opd no-16

研究点 (1)

Loading locations...

相似试验